Exploring the patient experience with Dr. D. Ross Camidge of the Academic Thoracic Oncology Medical Investigators Consortium (ATOMIC)

Dr. Camidge

Dr. D. Ross Camidge, Director of the Academic Thoracic Oncology Medical Investigators Consortium (ATOMIC), discusses his diagnosis in 2022 of Stage IV EGFR-positive non-small cell lung cancer in an article published in ASTRO (American Society for Radiation Oncology) News.

Dr. Camidge also explores the cancer patient experience from his unique perspective as a treatment provider, researcher and patient in a Cracking Cancer podcast episode and a video interview with The Patient Story.

Continue reading

ASCO Gastrointestinal Cancers Symposium – January 8-10, 2026

ASCO GI Cancers Symposium logo

We are excited to attend the 2026 ASCO Gastrointestinal Cancers Symposium, held in San Francisco on January 8-10, 2026. Our semi-annual Investigator’s Meeting of the Academic GI Cancer Consortium (AGICC)​ will be held on Thursday, January 8th, bringing together AGICC researchers to discuss new developments, collaboration opportunities and potential studies for 2026. 

Continue reading

Advances in Lung Cancer Research

Thoracic Oncology

As the second leading cause of cancer in both men and women in the U.S., small cell and non-small cell lung cancer affects thousands of people each year. In recent years, advances in diagnosis and treatment have improved drastically, enhancing quality of life and increasing the length of life for patients. 

Continue reading

2025 ASCO Annual Meeting Recap

2025 ASCO Annual Meeting

The Oncology Consortia of Criterium held their annual Investigator Meetings at the 2025 ASCO Annual Meeting. These gatherings foster an invaluable collaboration and innovation among leading experts in the field, across a wide range of institutions – driving forward our shared mission to advance cancer research and improve patient outcomes.

Continue reading

Podcast Interview with Dr. D. Ross Camidge and Dr. David Gerber of the Academic Thoracic Oncology Medical Investigators Consortium (ATOMIC)

Dr. D. Ross Camidge

Dr. D. Ross Camidge, Director of the Academic Thoracic Oncology Medical Investigators Consortium (ATOMIC), and Dr. David Gerber, a member of ATOMIC and Associate Professor of Internal Medicine within the Hematology/Oncology Division at UT Southwestern Medical Center, discuss how a liberal arts education can serve as a foundation for a successful medical career, the benefits of face-to-face, personalized patient connections versus digital interactions, and the value in keeping a humble and service-focused approach when providing patient care.

Continue reading